About The Study: The efficacy and safety observed in this randomized clinical trial suggest that low-dose atropine may provide a treatment option for childhood myopia progression.
Authors: Karla Zadnik, O.D., Ph.D., of the Ohio State University College of Optometry in Columbus, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaophthalmol.2023.2097)
Editor’s Note : Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2023.2097?guestAccessKey=cefa1859-d64c-478f-991c-4cd69da0a3a6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060123
JAMA Ophthalmology